Do tocolytic agents stop preterm labor? A critical and comprehensive review of efficacy and safety

Higby K, Xenakis EM, Pauerstein CJ

doi:10.1016/0002-9378(93)90376-t

Do tocolytic agents stop preterm labor? A critical and comprehensive review of efficacy and safety

Higby K et al., 1993

American Journal of Obstetrics and Gynecology, 168(4), 1247-1259

DOI 10.1016/0002-9378(93)90376-t

Abstract

Objective

Our aim was to determine the efficacy and safety of tocolytic agents currently used to treat premature labor.

Study design

We carried out a comprehensive review of tocolytic agents in the treatment of premature labor. Three hundred twenty-eight studies published between 1933 and 1992 were analyzed.

Results

An analysis of randomized, placebo-controlled, clinical trials showed that magnesium sulfate is not better than placebo in the treatment of premature labor. beta-Adrenergic receptor agonists effectively stop premature labor for only 24 to 48 hours. Calcium channel blockers and oxytocin antagonists inhibit uterine contractions, but their role in stopping labor is undefined. Prostaglandin inhibitors appear to be effective in treating premature labor and have few adverse side effects.

Conclusions

The only tocolytic drugs that might be effective are the prostaglandin inhibitors. Tocolytic agents should be used only between 24 and 32 completed weeks of gestation. Magnesium sulfate should not be used to treat premature labor. Oxytocin antagonists should be used only in experimental clinical trials. Calcium channel blockers and beta-adrenergic receptor agonists inhibit uterine contractions but do not prolong gestation for longer than 48 hours.

Topics

Pregnancy > Preterm Birth > Prevention General OB/GYN > Clinical Practice > Guidelines

tocolytic agents preterm labor review, magnesium sulfate preterm labor ineffective, beta agonists preterm birth prevention, prostaglandin inhibitors preterm labor, calcium channel blockers tocolysis, oxytocin antagonists premature labor, stopping preterm contractions effectiveness, tocolytic drug safety efficacy, preterm labor treatment comparison, premature labor management protocols

Cite this article

Higby, K., Xenakis, E. M., & Pauerstein, C. J. (1993). Do tocolytic agents stop preterm labor? A critical and comprehensive review of efficacy and safety. *American journal of obstetrics and gynecology*, *168*(4), 1247-1259. https://doi.org/10.1016/0002-9378(93)90376-t

Keywords

Adrenergic beta-Agonists/therapeutic Use, Calcium Channel Blockers/therapeutic Use, Female, Humans, Magnesium Sulfate/therapeutic Use, Obstetric Labor, Premature/prevention & Control, Oxytocin/antagonists & Inhibitors, Pregnancy, Prostaglandin Antagonists/therapeutic Use, Randomized Controlled Trials As Topic, Tocolytic Agents/adverse Effects/therapeutic Use, Adrenergic beta-Agonists, Calcium Channel Blockers, Prostaglandin Antagonists, Tocolytic Agents, Oxytocin, Magnesium Sulfate,

Do tocolytic agents stop preterm labor? A critical and comprehensive review of efficacy and safety

Abstract

Topics

Cite this article

Keywords

Related articles

Home monitoring of uterine contractility. Summary of a workshop sponsored by the National Institute of Child Health and Human Development and the Bureau of Maternal and Child Health and Resources Development, Bethesda, Maryland, March 29 and 30, 1989

Ultrasound differentiation of the competent from the incompetent cervix: prevention of preterm delivery

Chapter 53: Dating the Beginning of Pregnancy

ACOG Practice Bulletin. Clinical management guidelines for obstetrician-gynecologist. Number 43, May 2003. Management of preterm labor